• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.79%

    Karyopharm Therapeutics, Inc. (KPTI)

    -NasdaqGS
    8.04 Down 0.59(6.84%) May 4, 4:00PM EDT
    Prev Close:8.63
    Open:8.63
    Bid:5.13 x 100
    Ask:11.93 x 400
    1y Target Est:17.43
    Beta:N/A
    Next Earnings Date: 9-May-16KPTI Earnings announcement
    Day's Range:7.97 - 8.67
    52wk Range:4.83 - 30.82
    Volume:216,402
    Avg Vol (3m):262,387
    Market Cap:288.48M
    P/E (ttm):N/A
    EPS (ttm):-3.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KPTI

    Comparison

    Symbol% ChgMkt Cap
    KPTIDown 6.84%288.48M
    MRKDown 0.49%151.81B
    ABTDown 1.17%55.99B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,284.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-3.14
    Quarterly EPS Est (Mar-16) :-0.74
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback